The phase 1/2 ONE-SHOT study assessed a single-fraction of high-dose SBRT for early biochemical disease control and safety in localized prostate cancer.
New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among ...
Prostate cancer affects 1 in 8 men, but experts say it’s highly treatable when caught early. A survivor shares how PSA ...
Daniel W. Lin, MD, reviews new guidance on using MRI, biomarkers, and more, to improve the detection of prostate cancer.
The Hearty Soul on MSN
What are the symptoms of prostate cancer and what should you check for?
Know the 8 prostate cancer symptoms to watch for, from urinary changes to bone pain, plus who is most at risk and when to get ...
Morning Overview on MSN
A year of added prostate-cancer therapy cut the odds the disease spreads, a major trial found
Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...
AdvanCell, a clinical-stage radiopharmaceutical developer, has inked a lease near Boston to produce its prostate cancer ...
He died three years later in 2015.
For decades, the sugar content in fruit juices has been blamed for causing blood glucose spikes that are linked to weight ...
Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results